- Trials with a EudraCT protocol (44,349)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (18,700)
44,349 result(s) found.
Displaying page 173 of 2,218.
| EudraCT Number: 2005-000915-80 | Sponsor Protocol Number: NB 2006 05 | Start Date*: 2005-09-06 | |||||||||||
| Sponsor Name:University of Birmingham | |||||||||||||
| Full Title: A phase II study of Topotecan-Vincristine-Doxorubicin (TVD) in children with stage 4 neuroblastoma failing to respond to COJEC | |||||||||||||
| Medical condition: Neuroblastoma | |||||||||||||
|
|||||||||||||
| Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Completed) IT (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2005-000333-38 | Sponsor Protocol Number: Hcy2005 | Start Date*: 2005-05-25 |
| Sponsor Name:Organisation name was not entered | ||
| Full Title: A randomized placebo-controlled trial to investigate blood pressure lowering effects of folic acid in patients with borderline hypertension. | ||
| Medical condition: Patients with hyperhomocysteinemia and high-normal blood pressure, otherwise healthy | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: DE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2004-002267-24 | Sponsor Protocol Number: CRAD001A2413 | Start Date*: 2005-07-29 | |||||||||||
| Sponsor Name:Novartis Pharma Services AG | |||||||||||||
| Full Title: Assessment of everolimus in addition to calcineurin inhibitors reduction in maintenance renal transplant recipients (ASCERTAIN) | |||||||||||||
| Medical condition: Renal transplantation | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: SE (Completed) FI (Completed) IT (Completed) ES (Completed) DK (Completed) CZ (Completed) HU (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2004-005223-18 | Sponsor Protocol Number: NRA6280030 | Start Date*: 2005-05-12 |
| Sponsor Name:Childrens´ Hospital Erlangen | ||
| Full Title: Evaluation of growth response in short children suffering from a disease with growth retardation and treated with Somatropin: A prospective, longitudinal non-randomised, open, phase II study | ||
| Medical condition: Genotropin®) is approved for treatment of short statured children in specific indications. A benefit can also be achieved in other pathological conditions that lead to growth retardation. Because ... | ||
| Disease: | ||
| Population Age: Children, Under 18 | Gender: Male, Female | |
| Trial protocol: DE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-002138-36 | Sponsor Protocol Number: UHL9927 | Start Date*: 2006-02-24 |
| Sponsor Name:University Hospital of Leicester NHS Trust | ||
| Full Title: Randomised placebo controlled trial of low dose prednisolone for 3-years in subjects with chronic obstructive pulmonary disease with a sputum eosinophilia | ||
| Medical condition: Chronic obstructive pulmonary disease with sputum eosinophilia>3% | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-002160-28 | Sponsor Protocol Number: hepatology_MT_2005-05 | Start Date*: 2005-09-23 |
| Sponsor Name:Medical University Graz,Department of Internal Medicine, Division of Gastroenterology and Hepatology | ||
| Full Title: Safety and efficacy of long-term treatment with atorvastatin in patients with primary biliary cirrhosis | ||
| Medical condition: Reduction of cardiovascular risk may become key for the management of PBC. Therefore information on safety and efficacy (lipid-lowering effects) of statins in chronic cholestatic disorders is essen... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: AT (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2004-004343-21 | Sponsor Protocol Number: LAM100036 | Start Date*: Information not available in EudraCT |
| Sponsor Name:GlaxoSmithKline Research and Development Ltd | ||
| Full Title: A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects with Primary Generalized Tonic-Clonic Seizures | ||
| Medical condition: Epilepsy - Primary genralised tonic clonic seizures | ||
| Disease: | ||
| Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2004-004346-40 | Sponsor Protocol Number: CRAD001A2418 | Start Date*: 2005-05-02 | |||||||||||
| Sponsor Name:Novartis Pharma GmbH | |||||||||||||
| Full Title: Full title of the trial : Multi-center, open-label, prospective, randomized, parallel group study investigating a CNI-free regimen with Myfortic® and Certican® in comparison to standard therapy wit... | |||||||||||||
| Medical condition: de novo kidney transplantation (cadaveric, living unrelated or living related) | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2005-002823-15 | Sponsor Protocol Number: 1968 | Start Date*: 2005-10-25 |
| Sponsor Name:Nottingham University Hospitals NHS Trust | ||
| Full Title: A PHASE I/II TRIAL OF THE USE OF SIROLIMUS (RAPAMUNE) AND LOW DOSE ARA-C IN OLDER PATIENTS WITH ACUTE MYELOID LEUKAEMIA (AML) | ||
| Medical condition: Acute myeloid leukaemia (AML) and high risk myelodysplasia (MDS) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-002432-10 | Sponsor Protocol Number: S308.3.005 | Start Date*: 2005-11-25 |
| Sponsor Name:Solvay Pharmaceuticals | ||
| Full Title: A multicenter, randomized, double-blind, placebo-controlled, ascending dose, parallel group study exploring effects of SLV308 up to 42 mg/day administered as an adjunctive therapy to l-dopa in pati... | ||
| Medical condition: Parkinson Disease late stage | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: MT (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2005-001324-36 | Sponsor Protocol Number: VERTA | Start Date*: 2005-11-08 |
| Sponsor Name:Instituto Oftalmológico de Alicante (VISSUM) | ||
| Full Title: ENSAYO CLÍNICO DE FASE IIIB, PROSPECTIVO, CONTROLADO, DOBLE CIEGO, ALEATORIZADO CON GRUPOS PARALELOS Y MULTICÉNTRICO PARA COMPARAR LA SEGURIDAD Y LA EFICACIA DE LA TERAPIA FOTODINÁMICA CON VERTEPOR... | ||
| Medical condition: Neovascularización coroidea (NVC) subfoveal secundaria a la degeneración macular asociada a la edad (DMAE) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) PT (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2005-001340-22 | Sponsor Protocol Number: BHT-3009-03 | Start Date*: 2005-08-12 |
| Sponsor Name:Bayhill Therapeutics | ||
| Full Title: BHT-3009 IMMUNOTHERAPY IN RELAPSING REMITTING MULTIPLE SCLEROSIS | ||
| Medical condition: Multiple sclerosis results from an auto-immune reaction characterized by inflammation within the nervous system. Myelin basic protein is a target of the autoimmune response and is generally regarde... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: GB (GB - no longer in EU/EEA) FI (Prematurely Ended) SK (Completed) CZ (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2005-001723-10 | Sponsor Protocol Number: 767905/012 | Start Date*: 2005-08-26 |
| Sponsor Name:GlaxoSmithKline R & D Limited | ||
| Full Title: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Efficacy and Safety of Alvimopan 0.5mg Once Daily and 0.5mg Twice Daily for 12 Weeks for the Treatment of O... | ||
| Medical condition: Opioid-induced bowel dysfunction | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: IE (Completed) FI (Completed) GB (Completed) DE (Completed) DK (Completed) EE (Completed) AT (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-001738-34 | Sponsor Protocol Number: 210-03 | Start Date*: 2005-07-13 |
| Sponsor Name:Medivir AB | ||
| Full Title: Phase 2 open-label study of MIV-210 in antiretroviral treatment experienced HIV-1 infected subjects | ||
| Medical condition: HIV-1 infection | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2004-004948-45 | Sponsor Protocol Number: EXTRADOS | Start Date*: 2005-05-08 |
| Sponsor Name:José Hernández-Quero. Hospital Clínico San Cecilio | ||
| Full Title: Open, multicenter and randomized study phase IV to evaluate the efficacy and safety of 24 weeks more of treatment in patients with chronic hepatitis C genotype 1 and/or 4 co-infected with human inm... | ||
| Medical condition: Chronic hepatitis C | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2004-004952-38 | Sponsor Protocol Number: MREC/04/4/016 | Start Date*: 2005-02-11 |
| Sponsor Name:Prof John Yarnold, Institute of Cancer Research | ||
| Full Title: Randomised phase II trial of hyperbaric oxygen therapy in patients with chronic arm lymphoedema after radiotherapy for early breast cancer (HOT) | ||
| Medical condition: Chronic radiation-induced arm lymphoedema. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2004-001060-50 | Sponsor Protocol Number: CSPP100A2303 | Start Date*: 2005-02-25 |
| Sponsor Name:Novartis Pharma Services AG | ||
| Full Title: An eight-week, randomized, double-blind, multi-center, active-controlled, parallel group study to evaluate the safety and efficacy of an aliskiren based regimen compared to a lisinopril based regim... | ||
| Medical condition: Hypertension | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: HU (Completed) ES (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2004-001083-43 | Sponsor Protocol Number: BAY 59-7939 / 11223 | Start Date*: 2004-11-23 | |||||||||||
| Sponsor Name:Bayer HealthCare AG | |||||||||||||
| Full Title: Oral Direct Factor Xa Inhibitor BAY 59-7939 in Patients with acute symptomatic Deep Vein Thrombosis ODIXa-DVT A prospective, randomized, multinational, multicenter, partially blinded, parallel-grou... | |||||||||||||
| Medical condition: Acute deep vein thrombosis | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: HU (Completed) GB (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2004-001588-22 | Sponsor Protocol Number: BUP-002/04 | Start Date*: 2005-06-16 |
| Sponsor Name:AZIENDA SANITARIA OSPEDALIERA "S. GIOVANNI BATTISTA DI TORINO" | ||
| Full Title: PHARMACOKINETIC/PHARMACODINAMIC STUDY OF TRANSDERMAL BUPRENORPHINE FOR TREATMENT OF CHRONIC, MEDIUM-SEVERE, NON-ONCOLOGIC PAIN. | ||
| Medical condition: PATIENTS WITH CHRONIC, MEDIUM-SEVERE, VASCULOPATIC PAIN NON-RESPONDERS TO FANS. | ||
| Disease: | ||
| Population Age: Elderly | Gender: Male, Female | |
| Trial protocol: IT (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2004-004573-29 | Sponsor Protocol Number: DORI-06 | Start Date*: 2005-01-21 | |||||||||||
| Sponsor Name:Peninsula Pharmaceuticals, Inc. | |||||||||||||
| Full Title: A Multicenter, Phase 3 Study to Confirm the Safety and Efficacy of Intravenous Doripenem in Complicated Lower Urinary Tract Infection or Pyelonephritis | |||||||||||||
| Medical condition: Complicated Lower Urinary Tract Infection or Pyelonephritis MedDRA: Lower urinary tract infection or pyelonephritis (10024981 and/or 10059517) | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: AT (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
